<DOC>
	<DOC>NCT02242370</DOC>
	<brief_summary>Study to assess the effect of Telmisartan on diastolic and systolic blood pressure and to establish the effect on patient's quality of life scores.</brief_summary>
	<brief_title>Effectiveness of MICARDISÂ® (Telmisartan) on Blood Pressure Control and Quality of Live in Patients With Essential Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<criteria>Patients with Stage I essential Hypertension (diastolic blood pressure 9099 mmHg, and/or systolic blood pressure 140159 mmHg) Signed informed consent form Females of childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>93 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>